Vildagliptin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg
Reference Brands: Galvus (EU)
Category:
Diabetes
Vildagliptin inhibits the enzyme DPP-4, which prolongs the activity of incretin hormones like GLP-1 and GIP. This enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner, improving glycemic control without causing hypoglycemia. It is well-tolerated and weight-neutral, making it ideal for type 2 diabetes management.
Vildagliptin Tablets is available in Tablets
and strengths such as 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vildagliptin Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vildagliptin Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Vildagliptin is a DPP-4 inhibitor used to manage type 2 diabetes mellitus by enhancing incretin levels, improving insulin secretion, and reducing glucagon production. While not FDA-approved in the USA, it holds EMA approval and is widely marketed in the EU under brand names like Galvus and Galvus Met. Vildagliptin is available as monotherapy or in fixed-dose combinations with metformin. EU regulatory bodies emphasize its safety, tolerability, and cardiovascular neutrality. Pharmatradz.com connects global buyers and suppliers to EU-approved vildagliptin formulations, enabling seamless B2B transactions in the regulated pharmaceutical market.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing